{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:44:26Z","timestamp":1786995866116,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111\\u20132314-B-182A-143"],"award-info":[{"award-number":["111\\u20132314-B-182A-143"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2321-B-182A-004"],"award-info":[{"award-number":["NSTC 112-2321-B-182A-004"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pnpbp.2025.111343","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:30:52Z","timestamp":1742945452000},"page":"111343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and validation of global tau severity score in Alzheimer's disease using Florzolotau (18F) PET"],"prefix":"10.1016","volume":"138","author":[{"given":"Mu-N","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-I","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ying","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111343_bb0005","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","article-title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease","volume":"91","author":"Aschenbrenner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0010","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00259-020-05156-4","article-title":"Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"48","author":"Bischof","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0020","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2004.06.018","article-title":"A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume","volume":"23","author":"Buckner","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnagi.2016.00145","article-title":"Hippocampal amyloid burden with downstream fusiform gyrus atrophy correlate with face matching task scores in early stage Alzheimer\u2019s disease","volume":"8","author":"Chang","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.721217","article-title":"Structural covariance network as an Endophenotype in Alzheimer\u2019s disease-susceptible single-nucleotide polymorphisms and the correlations with cognitive outcomes","volume":"13","author":"Chang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314635","article-title":"Impact of amyloid pathology in mild cognitive impairment subjects: the longitudinal cognition and surface morphometry data","volume":"23","author":"Chang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/pcn.13557","article-title":"Gray matter reserve determines glymphatic system function in young-onset Alzheimer\u2019s disease: evidenced by DTI-ALPS and compared with age-matched controls","volume":"77","author":"Chang","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/pcn.13680","article-title":"Distinct biological property of tau in tau-first cognitive proteinopathy: evidence by longitudinal clinical neuroimaging profiles and compared with late-onset Alzheimer disease","volume":"78","author":"Chang","year":"2024","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115607","article-title":"Clinical significance of the plasma biomarker panels in amyloid-negative and tau PET-positive amnestic patients: comparisons with Alzheimer\u2019s disease and unimpaired cognitive controls","volume":"25","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.24711","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","volume":"80","author":"Cho","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191240","article-title":"The nonlinear relationship between cerebrospinal fluid Abeta42 and tau in preclinical Alzheimer\u2019s disease","volume":"13","author":"de Leon","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0070","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1038\/s41467-022-32592-7","article-title":"Earlier Alzheimer\u2019s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading","volume":"13","author":"Frontzkowski","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s42003-020-1079-x","article-title":"beta-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline","volume":"3","author":"Hammond","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0080","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/00001756-200210070-00028","article-title":"Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease","volume":"13","author":"Ho","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111069","article-title":"Alzheimer\u2019s disease approaches - focusing on pathology, biomarkers and clinical trial candidates","volume":"134","author":"Hroudova","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/RLU.0000000000003164","article-title":"The imaging features and clinical associations of a novel tau PET tracer-18F-APN1607 in Alzheimer disease","volume":"45","author":"Hsu","year":"2020","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40658-016-0159-y","article-title":"Phantom criteria for qualification of brain FDG and amyloid PET across different cameras","volume":"3","author":"Ikari","year":"2016","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0110","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/RLU.0000000000003974","article-title":"Complementary utility of dopamine transporter and tau PET imaging in the diagnosis of progressive supranuclear palsy: a case report","volume":"47","author":"Jia","year":"2022","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","article-title":"Reducing between scanner differences in multi-center PET studies","volume":"46","author":"Joshi","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cortex.2015.10.014","article-title":"Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment","volume":"74","author":"Joubert","year":"2016","journal-title":"Cortex"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12101355","article-title":"In vivo tau burden is associated with abnormal brain functional connectivity in Alzheimer's disease: a (18)F-Florzolotau study","volume":"12","author":"Ju","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0135","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1097\/RLU.0000000000004853","article-title":"Nonfluent variant primary progressive aphasia on FDG, 11 C-PIB, and 18 F-APN-1607 PET imaging","volume":"48","author":"Li","year":"2023","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0140","first-page":"180","article-title":"Cognitive abilities screening instrument, Chinese version 2.0 (CASI C-2.0): administration and clinical application","volume":"21","author":"Lin","year":"2012","journal-title":"Acta Neurol. Taiwan."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0145","doi-asserted-by":"crossref","first-page":"1148054","DOI":"10.3389\/fnins.2023.1148054","article-title":"Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer\u2019s disease","volume":"17","author":"Lin","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-024-00397-x","article-title":"The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing","volume":"13","author":"Liu","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0891988706297086","article-title":"Early-onset Alzheimer\u2019s disease is associated with greater pathologic burden","volume":"20","author":"Marshall","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.838034","article-title":"Amyloid and tau positron emission tomography imaging in Alzheimer\u2019s disease and other tauopathies","volume":"14","author":"Maschio","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020290","article-title":"The sensitivity of tau tracers for the discrimination of Alzheimer\u2019s disease patients and healthy controls by PET","volume":"13","author":"Mohammadi","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0180","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/acschemneuro.8b00093","article-title":"Different positron emission tomography tau tracers bind to multiple binding sites on the tau fibril: insight from computational modeling","volume":"9","author":"Murugan","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0185","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0190","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/alz.12456","article-title":"Rates of longitudinal change in (18) F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer\u2019s disease","volume":"18","author":"Phillips","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0195","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3758\/BRM.40.3.879","article-title":"Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models","volume":"40","author":"Preacher","year":"2008","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0200","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0205","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/brain\/awx171","article-title":"Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease","volume":"140","author":"Scholl","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0210","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.117.200006","article-title":"Flortaucipir F 18 quantitation using parametric estimation of reference signal intensity","volume":"59","author":"Southekal","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000443277","article-title":"Cranial magnetic resonance imaging in elderly American Indians: design, methods, and implementation of the cerebrovascular disease and its consequences in American Indians study","volume":"47","author":"Suchy-Dicey","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"42\u201358","key":"10.1016\/j.pnpbp.2025.111343_bb0220","article-title":"High-contrast in vivo imaging of tau pathologies in Alzheimer\u2019s and non-Alzheimer\u2019s disease tauopathies","volume":"109","author":"Tagai","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119763","article-title":"An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with (18)F-PM-PBB3 ((18)F-APN-1607)","volume":"264","author":"Tagai","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0230","first-page":"43","article-title":"Molecular genetics of early- and late-onset Alzheimer\u2019s disease","volume":"21","author":"Uddin","year":"2021","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0235","article-title":"CenTauR: toward a universal scale and masks for standardizing tau imaging studies","volume":"15","author":"Villemagne","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13195-017-0294-2","article-title":"Early- versus late-onset Alzheimer\u2019s disease in clinical practice: cognitive and global outcomes over 3 years","volume":"9","author":"Wattmo","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0245","article-title":"The worldwide Alzheimer\u2019s disease neuroimaging initiative: ADNI-3 updates and global perspectives","volume":"7","author":"Weber","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer's diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2023.102467","article-title":"Spinal cord injury-activated C\/EBPbeta-AEP axis mediates cognitive impairment through APP C586\/tau N368 fragments spreading","volume":"227","author":"Wu","year":"2023","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102074","article-title":"A gamma-adducin cleavage fragment induces neurite deficits and synaptic dysfunction in Alzheimer\u2019s disease","volume":"203","author":"Xiong","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0265","article-title":"(18)F-APN-1607 tau positron emission tomography imaging for evaluating disease progression in Alzheimer\u2019s disease","volume":"13","author":"Xu","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0270","article-title":"Parametric estimation of reference signal intensity for semi-quantification of tau deposition: a Flortaucipir and [(18)F]-APN-1607 study","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111343_bb0275","first-page":"38","article-title":"Rate of early onset Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Zhu","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.pnpbp.2025.111343_bb0280","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.105.594929","article-title":"Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models","volume":"115","author":"Zou","year":"2007","journal-title":"Circulation"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:26:15Z","timestamp":1762284375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":56,"alternative-id":["S0278584625000971"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111343","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of global tau severity score in Alzheimer's disease using Florzolotau (18F) PET","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111343"}}